ARTICLES BY ROBERT MATJE
-
FDA And Quality Metrics: Where Do Things (Currently) Stand?7/27/2018
Are you ready to give the FDA more? “What?” you ask, as a manufacturer of API and finished goods. Are you ready to give them more data and information about your manufacturing process? You think, “Don’t they get all the necessary information from me during their inspections and from my filings?” Well, the answer is yes and no.
-
Too Little Or Too Late? Perspectives On FDA’s New Serialization Guidances4/11/2018
Looking forward, the U.S. pharmaceutical industry needs to be aware that the despite the FDA’s year-long delay in enforcement, the Drug Supply Chain Security Act (DSCSA, with its specific compliance deadlines, is still law and that it is only draft guidance from the FDA that identifies an intent not to enforce the DSCSA for one year.
This website uses cookies to ensure you get the best experience on our website. Learn more